Ciprofloxacin for Contacts of Cases of Meningococcal Meningitis as an Epidemic Response: Study Protocol for a Cluster-Randomized Trial

Coldiron, M; Alcoba, G; Ciglenecki, I; Hitchings, M; Djibo, A; Page, A; Langendorf, C; Grais, R

dc.contributor.author	Coldiron, M
dc.contributor.author	Alcoba, G
dc.contributor.author	Ciglenecki, I
dc.contributor.author	Hitchings, M
dc.contributor.author	Djibo, A
dc.contributor.author	Page, A
dc.contributor.author	Langendorf, C
dc.contributor.author	Grais, R
dc.date.accessioned	2017-07-06T18:06:13Z
dc.date.available	2017-07-06T18:06:13Z
dc.date.issued	2017-06-24
dc.date.submitted	2017-07-06
dc.identifier.citation	Ciprofloxacin for Contacts of Cases of Meningococcal Meningitis as an Epidemic Response: Study Protocol for a Cluster-Randomized Trial. 2017, 18 (1):294 Trials	en
dc.identifier.issn	1745-6215
dc.identifier.pmid	28646924
dc.identifier.doi	10.1186/s13063-017-2028-y
dc.identifier.uri	http://hdl.handle.net/10144/618956
dc.description.abstract	Epidemics of meningococcal meningitis are common in the "African meningitis belt." Current response strategies include reactive vaccination campaigns, which are often organized too late to have maximal impact. A novel strain of Neisseria meningitidis serogroup C has been circulating in recent years, and vaccine supplies are limited. An evaluation of chemoprophylaxis with single-dose ciprofloxacin for household contacts of meningitis cases has therefore been recommended.
dc.language.iso	en	en
dc.publisher	BioMed Central	en
dc.rights	Archived with thanks to Trials	en
dc.title	Ciprofloxacin for Contacts of Cases of Meningococcal Meningitis as an Epidemic Response: Study Protocol for a Cluster-Randomized Trial	en
dc.identifier.journal	Trials	en
refterms.dateFOA	2019-03-04T13:29:33Z
html.description.abstract	Epidemics of meningococcal meningitis are common in the "African meningitis belt." Current response strategies include reactive vaccination campaigns, which are often organized too late to have maximal impact. A novel strain of Neisseria meningitidis serogroup C has been circulating in recent years, and vaccine supplies are limited. An evaluation of chemoprophylaxis with single-dose ciprofloxacin for household contacts of meningitis cases has therefore been recommended.